Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Drug or technology

Dex2

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 17, 2026 · PHASE 2 TRIAL

Trial of a Vaccination With Tumor Antigen-loaded Dendritic Cell-derived Exosomes

ClinicalTrials.gov

Phase 2 trial of an experimental immunotherapy in non-small-cell lung cancer, completed but with no results reported in this registry record; cannot assess efficacy or safety.

PreliminaryDex2 Gustave Roussy, Cancer Campus, Grand Paris NCT01159288

Reported

Planned enrollment47

Actual enrollment41

PhasePHASE 2

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support